39 67

Cited 1 times in

Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment

Authors
 Kyung-Soo Kim  ;  Byung-Wan Lee  ;  Yong Jin Kim  ;  Dae Ho Lee  ;  Bong-Soo Cha  ;  Cheol-Young Park 
Citation
 DIABETES & METABOLISM JOURNAL, Vol.43(2) : 127-143, 2019 
Journal Title
 DIABETES & METABOLISM JOURNAL 
ISSN
 2233-6079 
Issue Date
2019
Keywords
Diabetes mellitus ; Diabetes mellitus, type 2 ; Fatty liver ; Liver diseases ; Metabolic diseases ; Non-alcoholic fatty liver disease ; Therapeutics
Abstract
Nonalcoholic fatty liver disease (NAFLD) and diabetes are common metabolic disorders that are often comorbid conditions. Among many proposed treatments, weight reduction is the only approved option for NAFLD to date. However, it is not easy to maintain weight loss by lifestyle modification alone; pharmacological treatments are helpful in this regard. Although many drugs have been investigated, pioglitazone could be a first-line therapy in patients with NAFLD and diabetes. Many more drugs are currently being developed and investigated, and it is likely that combination strategies will be used for future treatment of NAFLD and diabetes. Attention should be paid to the management of NAFLD and diabetes and efforts should be made to intervene early and individualize treatment of NAFLD in patients with diabetes.
Files in This Item:
T201901672.pdf Download
DOI
10.4093/dmj.2019.0034
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Lee, Byung Wan(이병완) ORCID logo https://orcid.org/0000-0002-9899-4992
Cha, Bong Soo(차봉수) ORCID logo https://orcid.org/0000-0003-0542-2854
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/170036
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse